FAUCI DIARY ARCHIVE — Sunday, September 11, 2011 https://faucisdiary.com/diary/2011-09-11 Text below is verbatim from the released PDFs, with the original line breaks. ============================================================================== DIARY ENTRY — Sunday, September 11, 2011 Source: Diary Prequel, pp. 252–255 of 2026.07.27_Diary-Prequel-.pdf Words: 1119 ------------------------------------------------------------------------------ 10th Anniversary of “9/11”. Much commemoration going on in NYC and DC. Of note last week on Sept. 9 went to meeting in White House EEOB 530 with Eric Goosby, Gayle Smith and David Lane, Jeff Crowley and Dana DeRuiter (White House); Lois Quam (USAID), Ariel Pablos-Mendez (USAID), Tom Frieden on the phone; Nils Daulaire and Howard Koh (DHHS) and others. Purpose of the meeting was to plan a strategy that the WH and the POTUS should take in addressing and utilizing the recent scientific advances associated with HIV prevention, particularly treatment as prevention (HPTN-052) in turning around the HIV pandemic. In essence it was a meeting to figure out how we can implement what I proposed in Rome at the IAS meeting in July, 2011. Eric Goosby and Gayle Smith want me to directly brief the POTUS on this. It remains to be seen whether this happens. Clearly, the activists want more money to go to PEPFAR for treatment and prevention. However, there are major budget constraints. The WH is afraid of demonstrations during the upcoming IAS meeting in Washington in the summer of 2012 – right before the election. They have to walk a fine line between promising more money, which will inflame the right and doing nothing, which will inflame the left. It seems that they are calling me in to help them with this. More later…… Sept. 13 -14, 2011 – Beautiful crisp sunny day in DC. Started 09/13/11 with breakfast at the Four Seasons in Georgetown at 7:00 Am with Bill Gates. Also present from the Bill and Melinda Gates Foundation (BMGF) was Stefano Bertozzi. The theme was that Bill is reluctant to fund (with NIAID) the proposed South Africa (RSA) and Thailand vaccine trial for licensure since he thinks that the companies are charging too much money for the protein (env – made by Novartis). In addition, he does not think that the results will lead to a marketable product. However, we need the private sector or else we will never get a vaccine made for HIV. The quid pro quo for us is that if we go with a regulatory (licensure) trial in RSA and Thailand, the companies (Sanofi-Pasteur and Novartis) will work with us on a research trial of comparing several products in RSA, which is what we really want. I convinced Bill that this was a necessary evil and that although it was an imperfect situation, it is still the only deal around since the product – Pox Vector + Protein boost was the one that gave the only positive result in a vaccine trial to this point (RV144 – conducted in Thailand 2 years ago). In addition, there are some possible correlates of immunity associated with RV144. We ended the breakfast with a mutual commitment to work together on this. Also, Bill had some interesting a bit “off the wall” ideas about making a universal virus vector into which you can insert genes of important neutralizing antibodies for different microbes that can be an instantaneous antibody factory for bioterror organisms as well as for HIV, merely by changing the insert. Also, Bill does not believe in treatment as prevention from a practical or logistic point of view. Went on to participate in a 2 day meeting run by the George W. Bush Presidential Center – “The Summit to Save Lives” held at the Mellon Auditorium on Constitution Avenue, N.W. I was on the panel to discuss the leveraging of PEPFAR resources and infrastructure to do screening and treatment of cervical cancer in Africa and Latin America. I studied up on HVP and cervical cancer and we the “scientific expert” on the panel that included Eric Goosby (PEPFAR), Grosbeck Parham (C0-Director of Cervical Cancer Prevention program, Zambia), Dr. Beatrice Wiaffe Addai – president of Breast Care International. Panel Chaired by Jennifer Griffin, National Security Correspondence, together for HRC on the same subject that I spoke on in Rome – “The Science has now shown that we can end the AIDS pandemic – we need to implement” Only difference is that she will say that we can do it by increasing efficiencies PLUS having other partners (donors and host countries) put in a greater share. I said that we should put in more resources. The speech spins off the document mentioned above that we were asked to put together following the Sept. 9 meeting (see above). The main issue is that we will raise our goal of 4 million on treatment through PEPFAR by 2013 to 6 million by 2013. With much input from me and CDC, Eric Goosby put together a nice document explaining the importance of increasing this goal and having certain host countries such as South Africa and Rwanda assume more of the cost of treatment so that we can concentrate on countries with less resources such as DRC, Cameroon, Malawi, Zimbabwe. Also, we can use more bulk purchases etc. TODAY – (10/13/11) we had an important meeting in the Situation Room of the White House from 4:00 to 5:30 PM. Gayle Smith instigated the meeting. It was a Deputies Meeting chaired by Denis McDonough (Deputy National Security Advisor – Deputy to Thomas Donilon). He was very good and sympathetic to our goal. Also there were: Cheryl Mills, Eric Goosby, Tom Frieden, Steve Kosiak from OMB, Ariel Pablos-Mendez Nancy-Ann deParle, Dana DeRuiter from NSS, Samantha Power (NSS), Charles Hohman (OGAC). They called upon me to explain the scientific basis for our pushing to do more to turn around the trajectory of the Pandemic. I explained the details of HPTN-052. Great meeting – this may lead to an acceleration of our efforts. Also, Denis McDonough asked us to put together a “Blue Sky” proposal that would ask for more resources in addition to the increased efficiencies that we are already planning. We may not get more money, but we can probably show the leadership to inspire others to invest more, i.e. other rich countries. More later……. Oct. 17-19, 2011 Eric and I among others worked on a paper that gave 2 options: Scenario 1 – increase efficiencies and have host countries take more responsibility and thus shift PEPFAR money to treatment as prevention. This ill raise the bar for goals to 6 million people on PEPFAR-paid Tx by 2013 and 8 million by 2015. Scenario 2 – get $2.5 billion more money from 2013-2015 and raise goal to 8 million on treatment by 2013 and 10 million by 2015. Mathematically modeled (done by CDC), this would “tip” the curve (of incidence) of the pandemic more sharply downward and would also have many secondary benefits of saving lives and hospitalization. Denis McDonough now refers to this as the “Fauci curve”.